These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 4399318)

  • 1. Time-dependence of ALS effects on immunological and haematopoietic activities in mice.
    Nouza K; Haskovcová H; Nĕmec M
    Folia Biol (Praha); 1971; 17(5):312-21. PubMed ID: 4399318
    [No Abstract]   [Full Text] [Related]  

  • 2. Conditioning recipients of hemopoietic cells with antilymphocytic serum (ALS) and partial-body irradiation.
    Kolb H; Thierfelder S; Baumann P; Balk O
    Rev Eur Etud Clin Biol; 1971 Oct; 16(8):810-4. PubMed ID: 4399647
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune response in tumor-bearing patients and animals. IV. Immunological competence in lymphoid cells of tumor-bearing mice.
    Sekiguchi M; Odaka T; Fujii G; Ishibashi Y
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):90-5. PubMed ID: 4392613
    [No Abstract]   [Full Text] [Related]  

  • 4. Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
    Monaco AP; Liegeois A; Wood ML; Clark AW
    Adv Nephrol Necker Hosp; 1975; 5():135-72. PubMed ID: 242206
    [No Abstract]   [Full Text] [Related]  

  • 5. Graft-versus-host reactions in mice. I. Kinetic and immunogenetic studies of alloantigen-sensitive units of lymphoid tissue.
    Bennett M
    Transplantation; 1971 Feb; 11(2):158-69. PubMed ID: 4397088
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of the graft vs. host reaction on the take and growth of normal and tumorous tissues].
    Shats VIa
    Patol Fiziol Eksp Ter; 1973; 17(1):77-81. PubMed ID: 4149834
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 8. [Importance of the immunological enhancement for the survival time of a homologous graft].
    Benkö A
    Z Gesamte Inn Med; 1971 Jun; 26(11):345-52. PubMed ID: 4397958
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological problems in organ transplantation (with reference to oncology)].
    Gazzera G
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(9):599-614. PubMed ID: 4932115
    [No Abstract]   [Full Text] [Related]  

  • 10. Different sensitivity of H-2K and H-2D incompatibility to ALS immunosuppression.
    Démant P; Nouza K
    Folia Biol (Praha); 1971; 17(6):410-3. PubMed ID: 4400221
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow.
    Müller-Ruchholtz W; Wottge HU; Müller-Hermelink HK
    Transplant Proc; 1976 Dec; 8(4):537-41. PubMed ID: 11584
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymosin, a thymic hormone influencing lymphoid cell immunological competence.
    White A; Goldstein AL
    Ciba Found Study Group; 1970; 36():3-23. PubMed ID: 4399435
    [No Abstract]   [Full Text] [Related]  

  • 13. Graft-versus-host disease.
    Gatti RA; Kersey JH; Yunis EJ; Good RA
    Prog Clin Pathol; 1973; 5():1-18. PubMed ID: 4150104
    [No Abstract]   [Full Text] [Related]  

  • 14. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro.
    Thierfelder S; Hoffmann-Fezer G; Rodt H; Doxiadis I; Eulitz M; Kummer U
    Transplantation; 1983 Mar; 35(3):249-54. PubMed ID: 6340277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 16. Allogeneic marrow transplants in cyclophosphamide treated mice.
    Santos GW; Owens AH
    Transplant Proc; 1969 Mar; 1(1):44-6. PubMed ID: 4400067
    [No Abstract]   [Full Text] [Related]  

  • 17. Mode of action of antilymphocyte sra (ALS).
    Harris NS; Merino GE; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):797-9. PubMed ID: 4398511
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergism between cortisol and antilymphocyte serum. I. Observations in murine allograft systems.
    Gunn A; Lance EM; Medawar PB; Nehlsen SL
    Ciba Found Study Group; 1970; 36():66-72. PubMed ID: 4399436
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytology and histology of haemopoietic cell transplantation under the influence of ALS in mice. II. The effect of marrow from donors pretreated with antilymphocyte serum (ALS) on the recipient.
    Thierfelder S; Rodriguez-Paradisi E; Mempel W; Beil E
    Clin Exp Immunol; 1971 Jan; 8(1):121-9. PubMed ID: 4395674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antilymphocyte serum (ALS) as immunosuppressive agent].
    Piardi W
    Folia Allergol (Roma); 1971; 18(1):27-68. PubMed ID: 4397372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.